Christopher Hoimes, DO

Instructor in the Department of Medicine
Email address christopher.hoimes@duke.edu

Education and Training

  • Fellowship, Medical Oncology, Yale University, 2006 - 2009
  • Residency, Internal Medicine, Penn State Milton S. Hershey Medical Center, 2002 - 2005
  • D.O., New York Institute of Technology, College of Osteopathic Medicine, 2001

Publications

Tzeng, Alice, C Marcela Diaz-Montero, Patricia A. Rayman, Jin S. Kim, Paul G. Pavicic, James H. Finke, Pedro C. Barata, et al. “Immunological Correlates of Response to Immune Checkpoint Inhibitors in Metastatic Urothelial Carcinoma.” Target Oncol 13, no. 5 (October 2018): 599–609. https://doi.org/10.1007/s11523-018-0595-9.

PMID
30267200
Full Text

Long, G. V., M. Milhem, A. Amin, C. J. Hoimes, T. Medina, R. M. Conry, C. Lao, et al. “Phase Ib/II, open label, multicenter, study of the combination of SD-101 and pembrolizumab in patients with advanced melanoma who are naïve to anti-PD-1 therapy.” Annals of Oncology : Official Journal of the European Society for Medical Oncology 29 (October 1, 2018): viii736. https://doi.org/10.1093/annonc/mdy424.055.

Full Text

Flaig, Thomas W., Philippe E. Spiess, Neeraj Agarwal, Rick Bangs, Stephen A. Boorjian, Mark K. Buyyounouski, Tracy M. Downs, et al. “NCCN Guidelines Insights: Bladder Cancer, Version 5.2018.” J Natl Compr Canc Netw 16, no. 9 (September 2018): 1041–53. https://doi.org/10.6004/jnccn.2018.0072.

PMID
30181416
Full Text

Kang, Kylie H., William Grubb, Komal Sawlani, Michael K. Gibson, Christopher J. Hoimes, Lisa R. Rogers, Pierre Lavertu, and Min Yao. “Immune checkpoint-mediated myositis and myasthenia gravis: A case report and review of evaluation and management.” Am J Otolaryngol 39, no. 5 (September 2018): 642–45. https://doi.org/10.1016/j.amjoto.2018.06.003.

PMID
29903623
Full Text

Ornstein, Moshe C., Claudia Marcela Diaz-Montero, Patricia Rayman, Paul Elson, Samuel Haywood, James H. Finke, Jin S. Kim, et al. “Myeloid-derived suppressors cells (MDSC) correlate with clinicopathologic factors and pathologic complete response (pCR) in patients with urothelial carcinoma (UC) undergoing cystectomy.” Urol Oncol 36, no. 9 (September 2018): 405–12. https://doi.org/10.1016/j.urolonc.2018.02.018.

PMID
29606341
Full Text

Ribas, Antoni, Mohammed M. Milhem, Christopher J. Hoimes, Asim Amin, Inderjit Mehmi, Christopher D. Lao, Robert Martin Conry, et al. “Phase 1b/2, open label, multicenter, study of the combination of SD-101 and pembrolizumab in patients with advanced melanoma who are naïve to anti-PD-1 therapy.” In Journal of Clinical Oncology, 36:9513–9513. American Society of Clinical Oncology (ASCO), 2018. https://doi.org/10.1200/jco.2018.36.15_suppl.9513.

Full Text

Agarwal, Neeraj, Sumanta K. Pal, Andrew W. Hahn, Roberto H. Nussenzveig, Gregory R. Pond, Sumati V. Gupta, Jue Wang, et al. “Characterization of metastatic urothelial carcinoma via comprehensive genomic profiling of circulating tumor DNA.” Cancer 124, no. 10 (May 15, 2018): 2115–24. https://doi.org/10.1002/cncr.31314.

PMID
29517810
Full Text

Rosenberg, Jonathan E., Noah M. Hahn, Meredith M. Regan, Lillian Werner, Ajjai Alva, Saby George, Joel Picus, et al. “Apatorsen plus docetaxel versus docetaxel alone in platinum-resistant metastatic urothelial carcinoma (Borealis-2).” Br J Cancer 118, no. 11 (May 2018): 1434–41. https://doi.org/10.1038/s41416-018-0087-9.

PMID
29765151
Full Text

Spiess, Philippe E., Neeraj Agarwal, Rick Bangs, Stephen A. Boorjian, Mark K. Buyyounouski, Peter E. Clark, Tracy M. Downs, et al. “Bladder Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology.” J Natl Compr Canc Netw 15, no. 10 (October 2017): 1240–67. https://doi.org/10.6004/jnccn.2017.0156.

PMID
28982750
Full Text

Powles, Thomas, Peter H. O’Donnell, Christophe Massard, Hendrik-Tobias Arkenau, Terence W. Friedlander, Christopher J. Hoimes, Jae Lyun Lee, et al. “Efficacy and Safety of Durvalumab in Locally Advanced or Metastatic Urothelial Carcinoma: Updated Results From a Phase 1/2 Open-label Study.” Jama Oncol 3, no. 9 (September 14, 2017): e172411. https://doi.org/10.1001/jamaoncol.2017.2411.

PMID
28817753
Full Text

Pages